RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Deutsche Cannabis Stock

Deutsche Cannabis Net Income 2025

Deutsche Cannabis Net Income

-9.7 M EUR

Ticker

HEMP.F

ISIN

DE000A0BVVK7

WKN

A0BVVK

In 2025, Deutsche Cannabis's profit amounted to -9.7 M EUR, a 883.4% increase from the -986,800 EUR profit recorded in the previous year.

The Deutsche Cannabis Net Income history

YEARNET INCOME (k EUR)
2019-9,704.2
2018-986.8
2017-144.2
20164.1
2015-95.9
2014-373.1
2013-110
2012-670
2011-280
2010-170
2009-120
2008-30
2007-250
2006-280
2005-220
2004-70
200310
2002-60
2001-4,710
2000-9,330

Deutsche Cannabis Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Deutsche Cannabis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Deutsche Cannabis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Deutsche Cannabis’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Deutsche Cannabis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Deutsche Cannabis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Deutsche Cannabis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Deutsche Cannabis’s growth potential.

Deutsche Cannabis Revenue, EBIT and net profit per share

DateDeutsche Cannabis RevenueDeutsche Cannabis EBITDeutsche Cannabis Net Income
201918,200 undefined-4.81 M undefined-9.7 M undefined
20180 undefined-981,000 undefined-986,800 undefined
20170 undefined-144,400 undefined-144,200 undefined
20160 undefined4,500 undefined4,100 undefined
20150 undefined-95,900 undefined-95,900 undefined
20140 undefined-67,900 undefined-373,100 undefined
20130 undefined-110,000 undefined-110,000 undefined
20120 undefined-220,000 undefined-670,000 undefined
20110 undefined-280,000 undefined-280,000 undefined
201050,000 undefined-170,000 undefined-170,000 undefined
20090 undefined-130,000 undefined-120,000 undefined
200880,000 undefined-50,000 undefined-30,000 undefined
20070 undefined-280,000 undefined-250,000 undefined
200610,000 undefined-310,000 undefined-280,000 undefined
200520,000 undefined-240,000 undefined-220,000 undefined
200460,000 undefined-130,000 undefined-70,000 undefined
20031.89 M undefined340,000 undefined10,000 undefined
2002260,000 undefined-410,000 undefined-60,000 undefined
2001190,000 undefined-3.08 M undefined-4.71 M undefined
200010.17 M undefined-10.33 M undefined-9.33 M undefined

Deutsche Cannabis stock margins

The Deutsche Cannabis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Deutsche Cannabis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Deutsche Cannabis.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Deutsche Cannabis's sales revenue. A higher gross margin percentage indicates that the Deutsche Cannabis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Deutsche Cannabis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Deutsche Cannabis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Deutsche Cannabis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Deutsche Cannabis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Deutsche Cannabis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Deutsche Cannabis Margin History

Deutsche Cannabis Gross marginDeutsche Cannabis Profit marginDeutsche Cannabis EBIT marginDeutsche Cannabis Profit margin
2019100 %-26,446.7 %-53,319.78 %
2018100 %0 %0 %
2017100 %0 %0 %
2016100 %0 %0 %
2015100 %0 %0 %
2014100 %0 %0 %
2013100 %0 %0 %
2012100 %0 %0 %
2011100 %0 %0 %
2010100 %-340 %-340 %
2009100 %0 %0 %
2008100 %-62.5 %-37.5 %
2007100 %0 %0 %
2006100 %-3,100 %-2,800 %
2005100 %-1,200 %-1,100 %
2004100 %-216.67 %-116.67 %
200354.5 %17.99 %0.53 %
2002100 %-157.69 %-23.08 %
2001-15.79 %-1,621.05 %-2,478.95 %
2000-26.55 %-101.57 %-91.74 %

Deutsche Cannabis Aktienanalyse

What does Deutsche Cannabis do?

The German Cannabis AG is a rising company that specializes in the production and sale of medical cannabis. The company was founded in 2018 and is headquartered in Frankfurt am Main. The history of the German Cannabis AG began when a group of investors came together to invest in the growing market for medical cannabis. They recognized the potential that cannabis has as a medical product and the growing demand for high-quality cannabis. The founders of the company made it their mission to breed the best hemp varieties and extract the active ingredients in order to deliver the highest possible quality to their customers. The business model of the German Cannabis AG is based on growing and distributing medical cannabis. The company has its own plantation in Portugal, where it grows cannabis in modern greenhouses. The cultivation area is currently around 30 hectares and is planned to be expanded in the future. The company is committed to meeting the highest quality standards and therefore relies on state-of-the-art technologies and processes. For example, only organic-certified seeds are used to ensure optimal quality and purity of the end product. The German Cannabis AG offers various divisions to meet the different needs of customers. These divisions include not only medical cannabis but also CBD products, cosmetics, and dietary supplements. In the medical cannabis division, the company seeks to provide doctors and patients with high-quality and reliable products. The individual needs and specific requirements are the main focus. The company produces various products such as oils, capsules, flowers, or extracts that are tailored to the needs of patients. These products are sold exclusively to pharmacies and are available by prescription only. The CBD products division includes oils, cosmetics, and dietary supplements based on cannabidiol (CBD). These products are legal and can be purchased online or in specialty stores without a prescription. The company also places great emphasis on quality and reliability in this division and conducts intensive research and development. The cosmetics division includes various products such as creams, ointments, and balms based on medical cannabis. These are specifically offered for the treatment of skin problems such as eczema, psoriasis, or skin inflammation. Natural ingredients are used, and synthetic products are avoided. The dietary supplements division is characterized by high-quality products such as capsules, powders, or oils enriched with medical cannabis. These products support the immune system, digestion, and overall vitality of the body. In summary, the German Cannabis AG is a rising company specializing in the production and sale of medical cannabis and related products. Quality and reliability are the focus, and intensive investment is made in research and development. The different divisions offer customers a wide range of products that are individually tailored to their needs. Deutsche Cannabis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Deutsche Cannabis's Profit Margins

The profit margins of Deutsche Cannabis represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Deutsche Cannabis's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Deutsche Cannabis's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Deutsche Cannabis's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Deutsche Cannabis’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Deutsche Cannabis stock

How much profit has Deutsche Cannabis made this year?

Deutsche Cannabis has made -9.7 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by 883.4% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Deutsche Cannabis publish its earnings?

Deutsche Cannabis publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Deutsche Cannabis?

The profits of Deutsche Cannabis are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Deutsche Cannabis?

You can learn more about the earnings of Deutsche Cannabis by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Deutsche Cannabis pay?

Over the past 12 months, Deutsche Cannabis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deutsche Cannabis is expected to pay a dividend of 0 EUR.

What is the dividend yield of Deutsche Cannabis?

The current dividend yield of Deutsche Cannabis is .

When does Deutsche Cannabis pay dividends?

Deutsche Cannabis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deutsche Cannabis?

Deutsche Cannabis paid dividends every year for the past 0 years.

What is the dividend of Deutsche Cannabis?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deutsche Cannabis located?

Deutsche Cannabis is assigned to the 'Communication' sector.

Wann musste ich die Aktien von Deutsche Cannabis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deutsche Cannabis from 8/25/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 8/25/2025.

When did Deutsche Cannabis pay the last dividend?

The last dividend was paid out on 8/25/2025.

What was the dividend of Deutsche Cannabis in the year 2024?

In the year 2024, Deutsche Cannabis distributed 0 EUR as dividends.

In which currency does Deutsche Cannabis pay out the dividend?

The dividends of Deutsche Cannabis are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Deutsche Cannabis stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Deutsche Cannabis

Our stock analysis for Deutsche Cannabis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deutsche Cannabis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.